Categories: News

Clover Health to Present at the 2021 Wells Fargo Virtual Healthcare Conference on September 9, 2021

NASHVILLE, Tenn., Aug. 26, 2021 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV), a technology company committed to improving health equity for America’s underserved seniors, today announced that CEO Vivek Garipalli and President & CTO Andrew Toy will present at the 2021 Wells Fargo Virtual Healthcare Conference on Thursday, September 9, 2021, at 3:20 p.m. Eastern Time.

A live webcast of the presentation will be accessible from Clover Health’s investor relations website at https://investors.cloverhealth.com/. An archived replay of the presentation will be available from the same website for 12 months following the live presentation.

About Clover Health
Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans. While our mission is to improve every life, we particularly focus on seniors who have historically lacked access to affordable high quality healthcare.

Contacts:
Investor Relations:
Derrick Nueman
investors@cloverhealth.com
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com

Staff

Recent Posts

MDaudit Recognized as One of Modern Healthcare’s Best in Business

WELLESLEY, MA / ACCESS Newswire / January 12, 2026 / MDaudit, an award-winning cloud-based continuous…

3 hours ago

MDaudit Recognized as One of Modern Healthcare’s Best in Business

WELLESLEY, MA / ACCESS Newswire / January 12, 2026 / MDaudit, an award-winning cloud-based continuous…

3 hours ago

US Med-Equip Recognized as One of Modern Healthcare’s Best in Business

Fast-Growing Rental Company Honored for Supply Chain Excellence Supporting Hospitals HOUSTON, TEXAS / ACCESS Newswire…

3 hours ago

US Med-Equip Recognized as One of Modern Healthcare’s Best in Business

Fast-Growing Rental Company Honored for Supply Chain Excellence Supporting Hospitals HOUSTON, TEXAS / ACCESS Newswire…

3 hours ago

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

$18M upfront payment to Jaguar ($16M upon deal closing and $2M upon completion of post-closing…

3 hours ago

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

$18M upfront payment to Jaguar ($16M upon deal closing and $2M upon completion of post-closing…

3 hours ago